Corrigendum to "TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma" [EBioMedicine 40 (2019) 446-456].

EBioMedicine

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China; Department of Hepatobiliary Surgery, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China. Electronic address:

Published: June 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127592PMC
http://dx.doi.org/10.1016/j.ebiom.2022.104074DOI Listing

Publication Analysis

Top Keywords

corrigendum "tnf-α
4
"tnf-α potential
4
potential therapeutic
4
therapeutic target
4
target overcome
4
overcome sorafenib
4
sorafenib resistance
4
resistance hepatocellular
4
hepatocellular carcinoma"
4
carcinoma" [ebiomedicine
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!